For instance, FGF5 derived from cancer-associated fibroblasts can activate FGFR2 on tumor cells, initiating downstream Keap1/Nrf2/HO-1 signaling and enhancing resistance to ferroptosis [30]. This evidence concerns the gene KEAP1 and neoplasm.